Position in AMGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$37,489,559
-$251,279 QoQ
Shares Held
103,528
-3.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#259
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. AMGN ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
This page
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,489,559 | 103,528 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $37,740,838 | 107,264 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $34,796,653 | 106,311 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $30,268,772 | 107,260 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $28,458,758 | 101,926 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $31,722,955 | 101,823 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $27,320,024 | 104,819 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $32,034,118 | 99,420 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $29,920,212 | 95,760 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $26,649,597 | 93,731 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $25,073,005 | 87,053 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $22,350,081 | 83,160 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $17,747,168 | 79,935 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $18,928,541 | 78,298 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $19,704,566 | 75,025 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $16,190,031 | 71,828 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $16,738,066 | 68,796 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $16,714,598 | 69,120 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $15,167,477 | 67,420 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $17,235,069 | 81,049 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $19,426,631 | 79,699 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $19,531,833 | 78,501 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $17,370,915 | 75,552 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $18,699,059 | 73,572 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $16,669,641 | 70,676 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $14,334,227 | 70,706 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||